These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21319199)

  • 1. Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States.
    Stepanova M; Kanwal F; El-Serag HB; Younossi ZM
    Hepatology; 2011 Mar; 53(3):737-45. PubMed ID: 21319199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage.
    Stepanova M; Younossi ZM
    Dig Dis Sci; 2015 Nov; 60(11):3248-51. PubMed ID: 25986525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis C virus and insurance coverage on mortality.
    Bush H; Paik J; Golabi P; de Avila L; Escheik C; Younossi ZM
    Am J Manag Care; 2019 Feb; 25(2):61-67. PubMed ID: 30763036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study.
    Ditah I; Al Bawardy B; Gonzalez HC; Saberi B; Ditah C; Kamath PS; Charlton M
    Am J Gastroenterol; 2015 Aug; 110(8):1126-33. PubMed ID: 25756239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment rates in patients with chronic hepatitis C after liver biopsy.
    Narasimhan G; Sargios TN; Kalakuntla R; Homel P; Clain DJ; Theise ND; Bodenheimer HC; Min AD
    J Viral Hepat; 2006 Nov; 13(11):783-6. PubMed ID: 17052279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of an underserved Hispanic population with chronic hepatitis C treated with pegylated-interferon and ribavirin in a government-sponsored clinic.
    Iturrino J; Sánchez CJ; Ortiz A; Romero CJ; Velázquez V; Costas P; Torres EA
    P R Health Sci J; 2011 Mar; 30(1):9-13. PubMed ID: 21449491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A government sponsored clinic for the evaluation and treatment of chronic hepatitis C in an underinsured population in Puerto Rico.
    Costas P; Ortiz A; Velázquez V; Torres EA
    P R Health Sci J; 2004 Jun; 23(2 Suppl):41-7. PubMed ID: 16929586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurance status and treatment candidacy of patients with hepatitis C: Taiwanese patients are luckier.
    Dai CY; Yeh ML; Huang JF; Chuang WL; Yu ML
    Hepatology; 2011 Apr; 53(4):1399; author reply 1400. PubMed ID: 21480345
    [No Abstract]   [Full Text] [Related]  

  • 9. High rates of uninsured among HCV-positive individuals.
    Ong JP; Collantes R; Pitts A; Martin L; Sheridan M; Younossi ZM
    J Clin Gastroenterol; 2005 Oct; 39(9):826-30. PubMed ID: 16145347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patients.
    Talal AH; LaFleur J; Hoop R; Pandya P; Martin P; Jacobson I; Han J; Korner EJ
    Aliment Pharmacol Ther; 2013 Feb; 37(4):473-81. PubMed ID: 23289640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sources of health insurance and characteristics of the uninsured: analysis of the March 2000 Current Population Survey.
    Fronstin P
    EBRI Issue Brief; 2000 Dec; (228):1-27. PubMed ID: 11191096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health insurance coverage and adverse experiences with physician availability: United States, 2012.
    Gindi RM; Kirzinger WK; Cohen RA
    NCHS Data Brief; 2013 Dec; (138):1-8. PubMed ID: 24352196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.
    Salomon JA; Weinstein MC; Hammitt JK; Goldie SJ
    JAMA; 2003 Jul; 290(2):228-37. PubMed ID: 12851278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health insurance status and hypertension monitoring and control in the United States.
    Duru OK; Vargas RB; Kermah D; Pan D; Norris KC
    Am J Hypertens; 2007 Apr; 20(4):348-53. PubMed ID: 17386339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sources of health insurance and characteristics of the uninsured: analysis of the March 1998 Current Population Survey.
    Fronstin P
    EBRI Issue Brief; 1998 Dec; (204):1-27. PubMed ID: 10345791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.
    Liu CJ; Chu YT; Shau WY; Kuo RN; Chen PJ; Lai MS
    Gut; 2014 Mar; 63(3):506-14. PubMed ID: 23676440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience.
    Alsaran K; Sabry A; Molhem A
    Ren Fail; 2013; 35(10):1305-9. PubMed ID: 24059964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.
    Muratori P; Muratori L; Guidi M; Granito A; Susca M; Lenzi M; Bianchi FB
    Clin Infect Dis; 2005 Feb; 40(4):501-7. PubMed ID: 15712070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sources of health insurance and characteristics of the uninsured: analysis of the March 2007 Current Population Survey.
    Fronstin P
    EBRI Issue Brief; 2007 Oct; (310):1-33. PubMed ID: 17987754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
    Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
    Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.